Your browser doesn't support javascript.
loading
Safety profile of fractional dosing of the 17DD Yellow Fever Vaccine among males and females: Experience of a community-based pharmacovigilance in Kinshasa, DR Congo.
Nzolo, Didier; Engo Biongo, Aline; Kuemmerle, Andrea; Lusakibanza, Mariano; Lula, Yves; Nsengi, Ntamabyaliro; Nsibu Ndosimao, Celestin; Tona Lutete, Gaston; Van Geertruyden, Jean-Pierre.
Affiliation
  • Nzolo D; Unit of Clinical Pharmacology and Pharmacovigilance, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo; Centre National de Pharmacovigilance, Kinshasa, The Democratic Republic of the Congo; Global Health Institute, University of Antwerp, Antwerp, Belgium. Electronic address: Did
  • Engo Biongo A; Unit of Clinical Pharmacology and Pharmacovigilance, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo; Centre National de Pharmacovigilance, Kinshasa, The Democratic Republic of the Congo.
  • Kuemmerle A; Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland. Electronic address: andrea.kuemmerle@swisstph.ch.
  • Lusakibanza M; Unit of Clinical Pharmacology and Pharmacovigilance, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo; Centre National de Pharmacovigilance, Kinshasa, The Democratic Republic of the Congo.
  • Lula Y; Unit of Clinical Pharmacology and Pharmacovigilance, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo; Centre National de Pharmacovigilance, Kinshasa, The Democratic Republic of the Congo; Global Health Institute, University of Antwerp, Antwerp, Belgium. Electronic address: yve
  • Nsengi N; Unit of Clinical Pharmacology and Pharmacovigilance, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo; Centre National de Pharmacovigilance, Kinshasa, The Democratic Republic of the Congo. Electronic address: nsengi.ntama@unikin.ac.cd.
  • Nsibu Ndosimao C; Unit of Clinical Pharmacology and Pharmacovigilance, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo; Centre National de Pharmacovigilance, Kinshasa, The Democratic Republic of the Congo.
  • Tona Lutete G; Unit of Clinical Pharmacology and Pharmacovigilance, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo; Centre National de Pharmacovigilance, Kinshasa, The Democratic Republic of the Congo.
  • Van Geertruyden JP; Global Health Institute, University of Antwerp, Antwerp, Belgium. Electronic address: jean-pierre.vangeertruyden@uantwerpen.be.
Vaccine ; 36(41): 6170-6182, 2018 10 01.
Article in En | MEDLINE | ID: mdl-30190119
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Yellow Fever Vaccine Type of study: Qualitative_research Limits: Adolescent / Adult / Female / Humans / Male Country/Region as subject: Africa Language: En Journal: Vaccine Year: 2018 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Yellow Fever Vaccine Type of study: Qualitative_research Limits: Adolescent / Adult / Female / Humans / Male Country/Region as subject: Africa Language: En Journal: Vaccine Year: 2018 Document type: Article